{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:45:00Z","timestamp":1791308700255,"version":"4.3.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000072","name":"NIDCR","doi-asserted-by":"publisher","award":["R21DE023046"],"award-info":[{"award-number":["R21DE023046"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.antiviral.2015.02.002","type":"journal-article","created":{"date-parts":[[2015,3,16]],"date-time":"2015-03-16T19:03:38Z","timestamp":1426532618000},"page":"46-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Effect of Leflunomide, Cidofovir and Ciprofloxacin on replication of BKPyV in a salivary gland in vitro culture system"],"prefix":"10.1016","volume":"118","author":[{"given":"Liesl K.","family":"Jeffers-Francis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Burger-Calderon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Webster-Cyriaque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2015.02.002_b0005","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1016\/j.transproceed.2006.10.163","article-title":"Utilization of Vero cells for primary and chronic BK virus infection","volume":"38","author":"Acott","year":"2006","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.antiviral.2015.02.002_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/0-387-32957-9_1","article-title":"Polyomaviruses and human diseases","volume":"577","author":"Ahsan","year":"2006","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.antiviral.2015.02.002_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/135965350701200104","article-title":"Inhibition of Simian virus 40 large T antigen helicase activity by fluoroquinolones","volume":"12","author":"Ali","year":"2007","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2015.02.002_b0020","first-page":"30","article-title":"FDA approves cidofovir for treatment of CMV retinitis. Food and Drug Administration","volume":"2","author":"Anon.","year":"1996","journal-title":"J. Int. Assoc. Physicians AIDS Care"},{"key":"10.1016\/j.antiviral.2015.02.002_b0025","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.micinf.2012.02.002","article-title":"BK polyomavirus: emerging pathogen","volume":"14","author":"Bennett","year":"2012","journal-title":"Microbes Infect."},{"key":"10.1016\/j.antiviral.2015.02.002_b0030","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.1600-6143.2008.02269.x","article-title":"Cidofovir inhibits polyomavirus BK replication in human renal tubular cells downstream of viral early gene expression","volume":"8","author":"Bernhoff","year":"2008","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.antiviral.2015.02.002_b0035","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1128\/JVI.01737-09","article-title":"Leflunomide inhibition of BK virus replication in renal tubular epithelial cells","volume":"84","author":"Bernhoff","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.02.002_b0040","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1128\/JVI.02777-13","article-title":"Replication of oral BK virus in human salivary gland cells","volume":"88","author":"Burger-Calderon","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.02.002_b0045","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00001622-199605000-00011","article-title":"Lymphoid infiltrates of the salivary glands: pathology, biology and clinical significance","volume":"8","author":"DiGiuseppe","year":"1996","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.antiviral.2015.02.002_b0050","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/00007890-200210150-00016","article-title":"Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urine","volume":"74","author":"Ding","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.antiviral.2015.02.002_b0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.bmt.1705886","article-title":"Polyomavirus BK infection in blood and marrow transplant recipients","volume":"41","author":"Dropulic","year":"2008","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.antiviral.2015.02.002_b0060","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1399-3062.2006.00153.x","article-title":"Update on BK virus entry and intracellular trafficking","volume":"8","author":"Dugan","year":"2006","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.02.002_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2004.03.007","article-title":"Inhibition of human cytomegalovirus signaling and replication by the immunosuppressant FK778","volume":"65","author":"Evers","year":"2005","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.02.002_b0070","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/01.TP.0000149338.97084.5F","article-title":"Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system","volume":"79","author":"Farasati","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.antiviral.2015.02.002_b0075","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.2215\/CJN.08261109","article-title":"Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation","volume":"5","author":"Gabardi","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.antiviral.2015.02.002_b0080","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1128\/AAC.00046-11","article-title":"CMX001 (1-O-hexadecyloxypropyl-cidofovir) inhibits polyomavirus JC replication in human brain progenitor-derived astrocytes","volume":"55","author":"Gosert","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2015.02.002_b0085","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1386-6346(02)00088-8","article-title":"Lactoferrin inhibits hepatitis B virus infection in cultured human hepatocytes","volume":"24","author":"Hara","year":"2002","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.antiviral.2015.02.002_b0090","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7883\/yoken1952.47.73","article-title":"Inhibition with lactoferrin of in vitro infection with human herpes virus","volume":"47","author":"Hasegawa","year":"1994","journal-title":"Jpn. J. Med. Sci. Biol."},{"key":"10.1016\/j.antiviral.2015.02.002_b0095","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1086\/431488","article-title":"BK virus: opportunity makes a pathogen","volume":"41","author":"Hirsch","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.02.002_b0100","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1473-3099(03)00770-9","article-title":"Polyomavirus BK","volume":"3","author":"Hirsch","year":"2003","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.02.002_b0105","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJMoa020439","article-title":"Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients","volume":"347","author":"Hirsch","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2015.02.002_b0110","first-page":"3091","article-title":"Polyomaviruses","volume":"vol. 2","author":"Imperiale","year":"2007"},{"key":"10.1016\/j.antiviral.2015.02.002_b0115","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0046-8177(88)80220-X","article-title":"Salivary gland lymphadenopathies associated with AIDS","volume":"19","author":"Ioachim","year":"1988","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.antiviral.2015.02.002_b0120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/0022034510396882","article-title":"Viruses and salivary gland disease (SGD): lessons from HIV SGD","volume":"23","author":"Jeffers","year":"2011","journal-title":"Adv. Dent. Res."},{"key":"10.1016\/j.antiviral.2015.02.002_b0125","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.virol.2009.07.022","article-title":"BK virus has tropism for human salivary gland cells in vitro: implications for transmission","volume":"394","author":"Jeffers","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2015.02.002_b0130","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/01.tp.0000181149.76113.50","article-title":"Treatment of renal allograft polyoma BK virus infection with leflunomide","volume":"81","author":"Josephson","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.antiviral.2015.02.002_b0135","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00007890-200101150-00031","article-title":"Inhibition of herpes simplex virus type 1 by the experimental immunosuppressive agent leflunomide","volume":"71","author":"Knight","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.antiviral.2015.02.002_b0140","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/nrneph.2012.64","article-title":"Management of polyomavirus-associated nephropathy in renal transplant recipients","volume":"8","author":"Kuypers","year":"2012","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.antiviral.2015.02.002_b0145","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/tid.12136","article-title":"Treatment of BK virus-associated hemorrhagic cystitis in pediatric hematopoietic stem cell transplant recipients with cidofovir: a single-center experience","volume":"15","author":"Kwon","year":"2013","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.02.002_b0150","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1086\/427291","article-title":"Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation","volume":"40","author":"Leung","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.02.002_b0155","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.virol.2013.01.024","article-title":"Characteristics of polyomavirus BK (BKPyV) infection in primary human urothelial cells","volume":"440","author":"Li","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2015.02.002_b0160","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1097\/TP.0b013e3182007be2","article-title":"Anti-BK virus mechanisms of sirolimus and leflunomide alone and in combination: toward a new therapy for BK virus infection","volume":"90","author":"Liacini","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.antiviral.2015.02.002_b0165","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.antiviral.2006.05.008","article-title":"Lactoferrin inhibits early steps of human BK polyomavirus infection","volume":"72","author":"Longhi","year":"2006","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.02.002_b0170","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.5858\/2000-124-1773-COSDIL","article-title":"Characteristics of salivary diffuse infiltrative lymphocytosis syndrome in West Africa","volume":"124","author":"McArthur","year":"2000","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.antiviral.2015.02.002_b0175","first-page":"Unit 26.2","article-title":"BK virus (BKV): infection, propagation, quantitation, purification, labeling, and analysis of cell entry","volume":"Chapter 26","author":"Moriyama","year":"2009","journal-title":"Curr. Protoc. Cell Biol."},{"key":"10.1016\/j.antiviral.2015.02.002_b0180","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJM200005043421802","article-title":"Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy","volume":"342","author":"Nickeleit","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2015.02.002_b0185","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0891-5520(05)70114-8","article-title":"Oral infections and other manifestations of HIV disease","volume":"13","author":"Patton","year":"1999","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"10.1016\/j.antiviral.2015.02.002_b0190","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1079-2104(00)70092-8","article-title":"Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy","volume":"89","author":"Patton","year":"2000","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"10.1016\/j.antiviral.2015.02.002_b0195","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0166-3542(88)90004-6","article-title":"Suppression of BK virus replication and cytopathic effect by inhibitors of prokaryotic DNA gyrase","volume":"9","author":"Portolani","year":"1988","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.02.002_b0200","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1586\/14787210.5.1.105","article-title":"Antivirals for the treatment of polyomavirus BK replication","volume":"5","author":"Rinaldo","year":"2007","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.antiviral.2015.02.002_b0205","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1128\/AAC.00974-10","article-title":"1-O-hexadecyloxypropyl cidofovir (CMX001) effectively inhibits polyomavirus BK replication in primary human renal tubular epithelial cells","volume":"54","author":"Rinaldo","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2015.02.002_b0210","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/jmv.23453","article-title":"Shedding of polyomavirus in the saliva of immunocompetent individuals","volume":"85","author":"Robaina","year":"2013","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2015.02.002_b0215","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3201\/eid1901.120563","article-title":"Polyomavirus in saliva of HIV-infected children, Brazil","volume":"19","author":"Robaina","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.02.002_b0220","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/ijc.20641","article-title":"Investigation of human brain tumors for the presence of polyomavirus genome sequences by two independent laboratories","volume":"113","author":"Rollison","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.antiviral.2015.02.002_b0225","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/(SICI)1099-1654(199709)7:3<145::AID-RMV196>3.0.CO;2-0","article-title":"Clinical uses of cidofovir","volume":"7","author":"Safrin","year":"1997","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2015.02.002_b0230","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/sj.bmt.1705678","article-title":"Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant","volume":"39","author":"Savona","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.antiviral.2015.02.002_b0235","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.antiviral.2011.07.012","article-title":"Fluoroquinolones inhibit human polyomavirus BK (BKV) replication in primary human kidney cells","volume":"92","author":"Sharma","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.02.002_b0240","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/1097-0142(19810801)48:3<745::AID-CNCR2820480314>3.0.CO;2-7","article-title":"A neoplastic epithelial duct cell line established from an irradiated human salivary gland","volume":"48","author":"Shirasuna","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.antiviral.2015.02.002_b0245","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1128\/AAC.01809-10","article-title":"Activities of different classes of acyclic nucleoside phosphonates against BK virus in primary human renal cells","volume":"55","author":"Topalis","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2015.02.002_b0250","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/01.TP.0000441825.72639.4f","article-title":"A novel treatment regimen for BK viremia","volume":"97","author":"Zaman","year":"2014","journal-title":"Transplantation"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215000303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215000303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T22:40:00Z","timestamp":1651531200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354215000303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":50,"alternative-id":["S0166354215000303"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.02.002","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Leflunomide, Cidofovir and Ciprofloxacin on replication of BKPyV in a salivary gland in vitro culture system","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}